News
The VARIPULSE™ Platform is the first Pulsed Field Ablation (PFA) system fully integrated with the CARTO™ 3 electroanatomical mapping system, designed to drive efficiency, reproducibility, and ...
At a lymphoma conference, experts sparred about treatment options, while an outside expert highlighted the value of each approach.
Marlborough: Boston Scientific Corporation has announced that the company has received approval from the U.S. Food and Drug ...
Bisoprolol is reaffirmed as a key cardioselective Beta-1-blocker across the cardiovascular disease (CVD) continuum, with a ...
AI’s diagnostic makeover is unfolding across every layer of medicine. Discover how it's helping doctors today!
The study began in February 2004, with its primary completion and estimated completion dates not specified. The last update was submitted on June 30, 2025. These dates are crucial as they indicate the ...
Most heart problems are asymptomatic at early stages as they generally develop slowly over many years. Damage to the arteries, which can lead to heart attacks and strokes, results from many small ...
The U.K.’s National Institute for Health and Care Excellence (NICE) recommends the use of pulsed field ablation as an option ...
23h
Medical Device Network on MSNNICE issues positive guidance for pulsed field ablation in AF treatmentThe decision follows NICE’s review of safety and efficacy data, including clinical and economic analyses showing that PFA ...
Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant ...
In this systematic review and meta-analysis, catheter ablation was found to reduce overall risk of ischemic stroke, ...
Explore the rise and market race of anti-IL23p19 therapies in Inflammatory Bowel Disease (IBD), specifically Ulcerative Colitis (UC). Stay informed on the latest advancements and treatment options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results